Get BusinessWeek just for free.

For me BusinessWeek is number one among business and financial magazines. I simply like the way how news and analysis are presented. What I prefer the most is especially December special edition with the projection for the global stock markets for the next year. Also with analysis and trends for c...

Research in Motion (RIMM) analysis.

Before last quarter results company shares slide already 35% after disappointing Q1. Weak forecast for current period triggered another 27% plunge. Earnings per share (86 cents) met expectations with revenue slightly above street consensus.Main reason why stocks got under selling pressure were low...

Total Capacity Utilization

Crude Oil Sharply Lower, Dollar Strong in Early Trading

Monday, September 29--Jim Wyckoff's Morning Web Log OVERNIGHT/EARLY MORNING DEVELOPMENTS The market features in overnight/early morning trading today are sharply lower crude oil and U.S. stock index futures prices, and a very strong U.S. dollar as the government's financial sector bailout packa...

As Financial Markets Circle the Drain, What Happens to Clean Energy?

by Richard T. Stuebias seen at Huffington PostAn investment banker was quoted in Sunday's Financial Times as stating that the global financial market "changed more in the past 10 days than it had in the previous 70 years."Given such a profound shattering of the status quo, I am skeptical that anyo...

US House defeats Bailout Bill. Markets plunge.

The controversial $700Billion bailout plan being pushed into the House today was to be the tipping point for the US economy and financial markets. With optimism swirling on the weekend that agreements had been finally reached on the bill, the one thing left to do was the most important. Vote on i...

Warren Buffett Biography - The Snowball.

Widely expected book goes on sale tomorrow, 29/09. It is first Warren Buffett biography called The Snowball. The book was written by Alice Schroeder, former Morgan Stanley insurance analyst. It offers the portrait of "The Oracle of Omaha", his value, his strategy and his experiences. But it is not...

Where are we headed from here ....in terms of capital pool allocations?

Where are we headed from here ....in terms of capital pool allocations? - by Ziad It is a fact that rapidly developing economies (RDEs) have increasingly become drivers of change -- and sometimes disruption -- in global financial markets. That has important implications for companies in the United...

"Fannie Mae Eases Credit To Aid Mortgage Lending" circa 1999, NY Times

http://query.nytimes.com/gst/fullpage.html?res=9C0DE7DB153EF933A0575AC0A96F958260sec=spon=partner=permalinkexprod=permalink Paragraph 8: ''From the perspective of many people, including me, this is another thrift industry growing up around us,'' said Peter Wallison a resident fellow at the America...

Gone fishing: Trip across Bulgaria.

It's time to take vacation. Next week I am going to travel across Bulgaria. Far away from my job and noisy city. Also to have rest from stock markets. Especially the major question mark about financial bail out.My stay in Bulgaria is coming to the end and it is time to explore the country a littl...

Corporate Profits After Tax

Weekly Wrap-up - The Dow Jones Industrial Average Ends with a 120-Point Gain But...

Earlier I said I thought that a reversal from the opening lows followed by a positive close would be at least a mildly encouraging sign. The Dow Jones Industrial Average (DJIA) succeeded on that front as it gained 1% on the day. However, the S&P 500 (SPX), Nasdaq Composite (COMP) and Russell 2...

Analysts Respond to 'Proposal'

Earlier today, Director of Zacks Equity Research, Dirk van Dijk, CFA, posted an entry called 'A Modest Proposal.' Since then,a couplesenior analysts from the department have issued their responses. Sheraz Mian, senior oil gas industry analyst: That's an interesting idea, using the $700B...

Alpharma Shares Edge Higher after It Rejects King Pharmaceuticals' Latest Offer

Shares of Alpharma (ALO: sentiment, chart, options) rose 1.6%, while King Pharmaceuticals (KG: sentiment, chart, options) dipped 1.2%, after ALO rejected King's latest buyout bid on grounds that it is inadequate. Alpharma has rejected 2 such offers so far, declini...

Taubman Highly Exposed to Retail

Taubman Centers, Inc. (TCO) is a real estate investment trust (REIT) engaged in owning, developing, acquiring, and operating regional shopping centers throughout the U.S. A large number of these shopping centers are strategically located in major metropolitan areas. The company's five lar...

Solar Sector Plunges after the House Passes Energy Bill, Different from the Senate Version

If you were following the solar sector this week, you might have seen analyst comments stating that "Christmas came early for the U.S. solar industry." My colleague Mark Fightmaster detailed the potential lift for the Claymore/MAC Global Solar Energy Index (TAN: sentiment, chart, option...

Somaxon Awaiting FDA Decision

Somaxon Pharmaceuticals (SOMX) is a specialty pharmaceutical company focused on the development and in-licensing of product candidates in the fields of psychiatry and neurology. The company is focused on advancing the clinical development of existing product candidates, with a long-term s...

3Com Will Keep at Lower Levels

3Com Corporation (COMS) has become a leader in the Chinese enterprise networking market. We are concerned about the future of COMS business in China as it reduces its dependence on Huawei as a reseller, which contributes close to a quarter of revenue. However, Huawei revenue is slowing ...

Thornburg Mortgage Announces Reverse Stock Split, Extends Exchange Offer

Apparently unsatisfied with its penny-stock status, Thornburg Mortgage (TMA: sentiment, chart, options) announced this morning that its common stock will undergo a 1-for-10 reverse split, effective Monday, September 29. The split will bring TMA into compliance with Section 802.0...

Genta to Stay Trading Below $1

Genta Incorporated (GNTA) is a biopharmaceutical company focused on developing and commercializing drugs for the treatment of cancer. The company's leading candidate, Genasense, got a 'non-approvable' notice from the FDA on December 15, 2006. The company filed an appeal with the FDA in Ap...

Aracruz Pulp Markets Tight

Brazil-based Aracruz Celulose S.A. (ARA) is the world's largest producer of bleached eucalyptus pulp, as well as one of the low-cost producers of this product. The company is responsible for 31% of the global supply of the product, which. is used in the production of a wide range of paper...

A Turnaround at TASER International Inc (TASR)?

I admit, I sometimes get sucked into infomercials. I don't know what it is but seeing Ron Popeil wielding a flavor injector makes me feel an uncontrollable urge to cook a chicken. I offer this bit of knowledge, and risk of sharing too much, because I wonder if that same infomercial weakness inf...

Nuvelo "Wait & See" After Merger

Nuvelo, Inc. (NUVO) is a biopharmaceutical company that makes drugs for acute cardiovascular and cancer therapy. On September 25, the San Carlos, California-based company announced that it has entered into a definitive merger agreement with privately held ARCA Biopharma, Inc. Under the te...

SINA Corp. Shows Olympic Bump

SINA Corporation (SINA) is one of the most well-known online brands in China. The company is a leading provider of online media and value-added information services to global Chinese community. The company continues to do well in its online brand advertising, and is increasing the gap bet...

A Modest Proposal

It is clear to me that we have to do something and do something soon to resolve the mess on Wall Street. The financial system is facing both a liquidity problem and a solvency problem. I would set up what would be in effect a U.S. sovereign wealth fund. This fund would then buy -- at curr...